JP Morgan Chase
MDXH icon

JP Morgan Chase’s MDxHealth MDXH Stock Holding History

JP Morgan Chase’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-536
Closed -$1.91K – 7752
2025
Q4 		$1.91K Buy
+536
New +$2.12K ﹤0.01% 6953

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase's MDXH Position: Q1 2026 in Review

JP Morgan Chase sold out of MDxHealth (MDXH) in Q1 2026, closing a stake of 536 shares — an estimated $1.91K sold.

JP Morgan Chase first reported a position in MDXH in Q4 2025 and held it in 1 quarter. The position peaked at $1.91K in Q4 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

  • JP Morgan Chase reported no remaining MDxHealth position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 536 MDxHealth shares in Q1 2026, an estimated $1.91K.
  • JP Morgan Chase first reported a position in MDxHealth in Q4 2025 and held it in 1 quarter.
  • JP Morgan Chase's MDxHealth position peaked at $1.91K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.